Tag: strategies

[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global AI in Synthetic Biology Market size & share revenue was valued at approximately USD 24.58 Billion in 2024 and is expected to reach USD 30.76 Billion in 2025 and is expected to reach around USD 192.95 Billion by 2034, at a CAGR of 28.63% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are Ginkgo Bioworks, Amyris, Thermo Fisher Scientific, Illumina, GenScript, Synthetic Genomics, Novozymes, LanzaTech, Zymergen, Twist Bioscience, Codexis, Cambrian Biopharma, Moderna, Editas Medicine, Vertex Pharmaceuticals, CRISPR Therapeutics, Arbor Biotechnologies, Synthego, Evonik Industries, Cargill, Others and others.

NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Greenbacker, an energy transition-focused investment manager and independent power producer, today announced the sale of a 51.2 MW portfolio of 64 operating solar assets to CleanCapital, a leading independent power producer specializing in distributed clean energy. This transaction reflects Greenbacker’s broader strategy to optimize its project fleet for long-term growth with selective sales of non-core assets and a sharpened focus on larger-scale clean energy projects. The sale also supports greater operational efficiency, allowing the firm to reallocate resources toward the construction of higher-impact projects across its pre-operating portfolio.

The SASE market is driven by cloud-first strategies and hybrid work models, with opportunities in AI-driven security, zero trust adoption, and cloud migration. North America leads, while APAC grows rapidly. Managed SASE services lower entry barriers, and AI and multi-cloud integrations are key differentiators.

Triton to retain minority interest in Kelvion